Skip to main content
. 2018 May 8;8:7201. doi: 10.1038/s41598-018-25350-7

Table 1.

Patient Characteristics.

Feature Grade III Grade IV
Age
<50 4 6
50–59 5 2
60–69 2 5
≥70 1 1
Gender
male 9 9
female 3 5
KPS
≤80 1 3
>80 11 10
NA 0 1
Dose
Median 33 GyE 34.5 GyE
Range 30–42 GyE 30–42 Gye
Status
PD 6 13
SD 4 0
Lost to FU 2 1